rs863223696
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3PP5
The NM_005120.3(MED12):c.4147G>A(p.Ala1383Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005120.3 missense
Scores
Clinical Significance
Conservation
Publications
- FG syndrome 1Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- MED12-related intellectual disability syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- X-linked intellectual disability with marfanoid habitusInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- blepharophimosis - intellectual disability syndrome, MKB typeInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- cholestasis-pigmentary retinopathy-cleft palate syndromeInheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Blepharophimosis - intellectual disability syndrome, MKB type Pathogenic:1Uncertain:1
The variant is not observed in the gnomAD v4.0.0 dataset. Predicted Consequence/Location: Missense variant Damaging effect on gene or gene product predicted by in silico programs is uncertain [REVEL: 0.51 (damaging >=0.6, benign <0.4), 3Cnet: 0.14 (damaging >=0.6, benign <0.15)]. Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000213624 /PMID: 26338144). The variant has been previously reported as assumed (i.e. paternity and maternity not confirmed) de novo in at least one similarly affected unrelated individual (PMID: 36271811). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
not provided Pathogenic:1
The A1383T variant in the MED12 gene has been reported previously as a pathogenic variant in two male siblings with microcephaly, dysmorphic features, failure to thrive, developmental delay, increased muscle tone, and chordee (Langely et al., 2015). The A1383T variant was not observed in approximately 6200 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The A1383T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret A1383T as a pathogenic variant. -
FG syndrome Pathogenic:1
This variant is not present in population databases (gnomAD no frequency). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MED12 protein function. ClinVar contains an entry for this variant (Variation ID: 213624). This missense change has been observed in individual(s) with clinical features of MED12-related conditions (PMID: 26338144, 36271811). In at least one individual the variant was observed to be de novo. This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 1383 of the MED12 protein (p.Ala1383Thr). -
Inborn genetic diseases Uncertain:1
- -
FG syndrome 1 Other:1
Reported in male sibs with nonspecific intellectual disability -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at